Omega Flex, Inc. — Form 10-Q Summary
Business Context and Reporting Period
Omega Flex manufactures and sells flexible metal hose, flexible gas piping, proprietary fittings, and related accessories through distributors, wholesalers, and OEMs. Operations are managed as one segment, with manufacturing facilities in the United States and United Kingdom. This report covers the three and six months ended June 30, 2020, compared with the corresponding 2019 periods. The financial statements are unaudited and prepared under U.S. GAAP.
Key Financial Metrics
| Metric | Q2 2020 | Q2 2019 | Six Months 2020 | Six Months 2019 |
|---|---|---|---|---|
| Net sales | $21.818 million | $26.809 million | $47.084 million | $53.597 million |
| Gross profit | $13.262 million | $16.736 million | $29.031 million | $33.682 million |
| Gross margin | 60.8% | 62.4% | 61.7% | 62.8% |
| Operating profit | $4.886 million | $5.144 million | $10.731 million | $10.735 million |
| Operating margin | 22.4% | 19.2% | 22.8% | 20.0% |
| Net income attributable to Omega Flex | $3.571 million | $3.983 million | $7.915 million | $8.365 million |
| Basic and diluted EPS | $0.35 | $0.39 | $0.78 | $0.83 |
Six-month operating cash flow was $9.303 million, compared with $5.079 million in the prior-year period. Capital expenditures were $0.187 million, compared with $0.722 million. Dividends paid were $5.653 million, compared with $4.844 million.
Cash and cash equivalents were $19.487 million at June 30, 2020, compared with $16.098 million at December 31, 2019. Total assets were $59.917 million and total liabilities were $20.255 million. The company had no borrowings outstanding at quarter-end and had access to a $15 million unsecured revolving credit facility maturing December 1, 2022. The facility was fully drawn during the quarter as a precaution during the COVID-19 crisis and repaid before quarter-end.
Accounts receivable were $14.113 million, inventories were $11.083 million, and shareholders’ equity was $39.662 million at June 30, 2020. The allowance for credit losses was $0.887 million. Operating lease liabilities totaled $0.602 million, including $0.311 million current.
Material Changes Versus the Prior Comparable Period
- Second-quarter sales declined 18.6%, primarily because of lower unit volume associated with reduced construction and economic activity during the COVID-19 pandemic.
- Six-month sales declined 12.2%. Management stated that pricing actions partly offset material-cost pressure and protected margins.
- Second-quarter gross margin decreased to 60.8% from 62.4%; management attributed the decline to lower production and reduced labor and overhead absorption.
- Second-quarter operating profit declined 5.0%, but operating margin increased to 22.4% from 19.2%, primarily because general and administrative expense fell 37.3%.
- General and administrative expense decreased by $2.298 million in the second quarter and by $3.539 million for the six months, largely because of lower legal and product-liability defense costs.
- Six-month operating profit was essentially flat despite lower sales, while operating margin improved to 22.8% from 20.0%.
- Interest income declined because the company held less invested cash, while interest expense increased because of the temporary revolver borrowing.
- The company received $2.453 million under the Paycheck Protection Program in April 2020 but repaid the loan by May 7, 2020 after subsequent government guidance.
- The company declared a regular quarterly dividend of $0.28 per share for the second quarter. A $35.330 million special dividend had been paid in December 2019.
Outlook, Risks, Contingencies, and Unusual Items
- Management reported that sales weakened early in the second quarter but progressively improved, with June sales and profitability exceeding June 2019. MediTrac medical gas piping benefited from demand related to temporary and retrofitted medical facilities, and industrial products benefited from pharmaceutical applications.
- Management stated that the reported results are not indicative of expected full-year results and cannot reasonably estimate the duration, severity, or overall financial impact of COVID-19.
- The company believes cash and available borrowing capacity will be sufficient for anticipated needs for at least the next twelve months.
- COVID-19 risks include prolonged shutdowns, reduced construction activity, supply-chain disruption, staffing shortages, customer and supplier distress, remote-work limitations, cybersecurity exposure, and possible impairment of goodwill. No goodwill impairment trigger was identified through June 30, 2020.
- One customer accounted for more than 10% of accounts receivable and more than 10% of sales in both comparable periods, creating customer-concentration risk.
- The company is defending product-liability claims, including a putative Missouri class action involving alleged lightning damage to flexible gas piping. Management believes the claims lack merit, but estimates aggregate exposure for current open claims, excluding the class action, at up to approximately $5.8 million within insurance deductibles or retentions. Recorded liabilities were $0.150 million at June 30, 2020.
- A United Kingdom legal dispute could require payment of estimated legal costs of $0.2 million to $0.5 million; no liability was recorded because the loss was not considered probable.
- Management reported effective disclosure controls and no material change in internal control over financial reporting during the period.
- No formal quantitative financial guidance was provided in the filing.
Most Important Facts for Investors to Verify
- Whether COVID-19-related construction weakness, supply-chain disruption, or customer concentration affects sales and margins in subsequent quarters.
- The sustainability of improved operating margins, particularly given lower production absorption and the unusually low legal-defense expense in 2020.
- Cash generation and dividend capacity relative to the company’s $15 million credit facility and future working-capital needs.
- The status and potential financial exposure of the Missouri class action, other product-liability claims, and the U.K. legal dispute.
- Whether prolonged COVID-19 effects create a goodwill impairment trigger or materially affect liquidity and operations.
- The implications of the company’s prior PPP application and repayment following government guidance.